Catheter Precision VTAK
NYSE VTAK
$0.17 -0.02 (-10.83%)
As of: Sep 9, 2026 · 3:59 PM EDT

Catheter Precision (VTAK) Operating Income Growth (1y) (2018 - 2026)

Analysis

Catheter Precision (VTAK) Operating Income Growth (1y) (2018 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc Growth (1y) (Qtr)
1 Abbott Laboratories 187.42 Bn 182.47 Bn 7.27 Bn -17.50%
2 Intuitive Surgical 129.78 Bn 124.69 Bn 1.96 Bn 30.74%
3 Medtronic 120.53 Bn 112.33 Bn 6.34 Bn 22.08%
4 Stryker 116.28 Bn 112.80 Bn 4.50 Bn 49.06%
5 Boston Scientific 69.29 Bn 68.99 Bn 3.85 Bn 43.83%
6 Edwards Lifesciences 51.83 Bn 47.68 Bn 1.35 Bn 24.81%
7 Alcon 34.36 Bn 32.91 Bn 1.68 Bn -95.55%
8 Dexcom 33.17 Bn 31.23 Bn 830.00 Mn 49.72%
9 Steris 21.90 Bn 21.43 Bn 684.20 Mn 16.18%
10 Catheter Precision 553,488.01 -1.71 Mn 98,000.00 15.60%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 15.60%
Mar 31, 2026 35.16%
Dec 31, 2025 -223.21%
Sep 30, 2025 -5.67%
Jun 30, 2025 -72.47%
Mar 31, 2025 -36.66%
Dec 31, 2024 -17.48%
Sep 30, 2024 -4.73%
Jun 30, 2024 56.93%
Mar 31, 2024 96.07%
Dec 31, 2023 68.39%
Sep 30, 2023 42.92%
Jun 30, 2023 25.44%
Mar 31, 2023 -1,108.14%
Dec 31, 2022 0.59%
Sep 30, 2022 35.31%
Jun 30, 2022 -16.82%
Mar 31, 2022 19.90%
Dec 31, 2021 19.19%
Sep 30, 2021 1.51%